Osmaniye, D., Kurban, B., Sağlık, B. N., Levent, S., Özkay, Y., & Kaplancıklı, Z. A. (2021). Novel Thiosemicarbazone Derivatives: In Vitro and In Silico Evaluation as Potential MAO-B Inhibitors. MDPI AG.
Cita Chicago Style (17a ed.)Osmaniye, Derya, Berkant Kurban, Begüm Nurpelin Sağlık, Serkan Levent, Yusuf Özkay, y Zafer Asım Kaplancıklı. Novel Thiosemicarbazone Derivatives: In Vitro and In Silico Evaluation as Potential MAO-B Inhibitors. MDPI AG, 2021.
Cita MLA (8a ed.)Osmaniye, Derya, et al. Novel Thiosemicarbazone Derivatives: In Vitro and In Silico Evaluation as Potential MAO-B Inhibitors. MDPI AG, 2021.
Precaución: Estas citas no son 100% exactas.